Cover Image

A Correlation Evaluation Between the Peripheral Blood Index and the Prognosis of Advanced Esophageal Squamous Cell Carcinoma Patients Treated with Camrelizumab

Haotian Shang, Yanan Chen, Qiulu Wang, Yongliang Yang, Jingyu Zhang Department of Oncology, Clinical College of Second People's Hospital of Lianyungang, Bengbu Medical College, Lianyungang, People's Republic of ChinaCorrespondence: Jingyu Zhang, Department of Oncology, Clinical College of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Shang H (Author), Chen Y (Author), Wang Q (Author), Yang Y (Author), Zhang J (Author)
Format:	Book
Published:	Dove Medical Press, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cost-Effectiveness Analysis of Camrelizumab Versus Chemotherapy as Second-Line Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma
by: Hongfu Cai, et al.
Published: (2021)

Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma
by: Pingyu Chen, et al.
Published: (2024)

The Systemic Immune-Inflammation Index as an Independent Predictor of Survival in Patients with Locally Advanced Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Radiotherapy
by: Zhang H, et al.
Published: (2024)

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China
by: Taihang Shao, et al.
Published: (2022)

Significance of the prognostic nutritional index in patients with esophageal squamous cell carcinoma
by: Feng JF, et al.
Published: (2013)

Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients
by: Juanfang Liu, et al.
Published: (2021)

PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population
by: Lulu Rong, et al.
Published: (2019)

A Case of Esophageal Squamous Cell Carcinoma Arising from Esophageal Squamous Papilloma
by: Jae Yeong Cho, et al.
Published: (2019)

Poor Prognosis of Oral Squamous Cell Carcinoma Correlates With ITGA6
by: Churen Zhang, et al.
Published: (2023)

Esophageal squamous papilloma
by: Seham M Seif, et al.
Published: (2015)

Metabolic reprogramming in esophageal squamous cell carcinoma
by: Ziyi Wang, et al.
Published: (2024)

A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma
by: Yang Y, et al.
Published: (2023)

Immune-Related Colitis Induced by Camrelizumab: A Case Report
by: Cheng S, et al.
Published: (2023)

Esophageal Neuroendocrine Carcinoma With Focal Squamous Cell Carcinoma Component
by: Min Kyun Kang, et al.
Published: (2020)

Development of Nomogram Models Based on Peripheral Blood Score and Clinicopathological Parameters to Predict Preoperative Advanced Stage and Prognosis for Epithelial Ovarian Cancer Patients
by: Bai G, et al.
Published: (2023)

Tumor-Infiltrating CD4+ Central Memory T Cells Correlated with Favorable Prognosis in Oral Squamous Cell Carcinoma
by: Wu J, et al.
Published: (2022)

Predicting Outcome in Combination Treatment of TACE and Camrelizumab for Advanced Hepatocellular carcinoma: Tumor Hypervascularity and Reactive Cutaneous Capillary Endothelial Proliferation
by: Yin L, et al.
Published: (2022)

Prognostic Value of Lactate Dehydrogenase in Second-Line Immunotherapy for Advanced Esophageal Squamous Cell Carcinoma
by: Yan Li, et al.
Published: (2022)

Cost-Effectiveness Analysis of Tislelizumab Plus Chemotherapy as First-Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
by: Zhou C, et al.
Published: (2023)

Squamous cell carcinoma of the tongue: clinical and morphological analysis of 57 cases and correlation with prognosis
by: Marcelo Gadelha Vasconcelos, et al.
Published: (2014)

The Mural Form of Eosinophilic Esophagitis Is Accompanied by Superficial Esophageal Squamous Cell Carcinoma
by: Zhao Jingsheng, et al.
Published: (2012)

Oolong tea consumption and its interactions with a novel composite index on esophageal squamous cell carcinoma
by: Shuang Liu, et al.
Published: (2019)

Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study
by: Li H, et al.
Published: (2021)

APOC1 predicts a worse prognosis for esophageal squamous cell carcinoma and is associated with tumor immune infiltration during tumorigenesis
by: Xiying Cao, et al.
Published: (2023)

TLR3 Expression is a Potential Prognosis Biomarker and Shapes the Immune-Active Tumor Microenvironment in Esophageal Squamous Cell Carcinoma
by: Su R, et al.
Published: (2022)

Sugemalimab combined with chemotherapy for the treatment of advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis
by: Hongfu Cai, et al.
Published: (2024)

Comparison of cisplatinum/paclitaxel with cisplatinum/5-fluorouracil as first-line therapy for nonsurgical locally advanced esophageal squamous cell carcinoma patients
by: Hu GF, et al.
Published: (2016)

Massive Hepatocellular Carcinoma with Situs Inversus Totalis Achieved a Complete Response Following Camrelizumab Plus Apatinib and Combined with Two-Stage Hepatectomy: A Case Report
by: Wu Y, et al.
Published: (2023)

Economic Evaluation of First-Line Camrelizumab for Advanced Non-small-cell Lung Cancer in China
by: Guiyuan Xiang, et al.
Published: (2021)

A First-in-Human Dose Finding Study of Camrelizumab in Patients with Advanced or Metastatic Cancer in Australia
by: Lickliter JD, et al.
Published: (2020)

Baicalein Inhibits the Progression and Promotes Radiosensitivity of Esophageal Squamous Cell Carcinoma by Targeting HIF-1A
by: Guo D, et al.
Published: (2022)

Disparities in Survival Outcomes Between Locally Advanced Cervical Squamous Cell Carcinoma and Adenocarcinoma Treated with Chemoradiotherapy
by: Hong SS, et al.
Published: (2024)

Genomic and transcriptional characterization of early esophageal squamous cell carcinoma
by: Jingjing Zhao, et al.
Published: (2023)

Esophageal Squamous Cell Carcinoma Presenting as a Subepithelial Tumor
by: Soon Young Kim, et al.
Published: (2017)

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma
by: Zhu Y, et al.
Published: (2019)

Research on Correlations of miR-196a Expression with Progression and Prognosis of Cutaneous Squamous Cell Carcinoma
by: Zhang W, et al.
Published: (2022)

Circulating blood biomarkers correlated with the prognosis of advanced triple negative breast cancer
by: Xingyu Li, et al.
Published: (2024)

Identification of factors related to immunotherapy efficacy and prognosis in patients with advanced head and neck squamous cell carcinoma
by: Xuanli Xu, et al.
Published: (2021)

Case Report: Clinical complete response of advanced renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion by treated by camrelizumab and axitinib: A rare case report
by: Juping Zhao, et al.
Published: (2022)

A novel DNA damage repair gene-related prognostic model for evaluating the prognosis and tumor microenvironment infiltration of esophageal squamous cell carcinoma
by: Dong Guo, et al.
Published: (2023)